<HTML><HEAD><META http-equiv="Content-type" content="text/html;charset=UTF-8"></HEAD><BODY><DIV><P><BR>               <BR>               <BR>               17 PATIENT COUNSELING INFORMATION<BR>               <BR>                  Advise patients to contact a healthcare professional for any of the following:<BR>                  <BR>                     Skin and ocular/visual changes [see Boxed Warning and Warnings and Precautions (5.1), (5.8)]<BR>                     <BR>                     Signs and symptoms of infusion reactions, including fever, chills, or breathing problems [see Boxed Warning, Dosage and Administration (2.1), Warnings and Precautions (5.2), and Adverse Reactions (6.1, 6.3)]<BR>                     <BR>                     Diarrhea and dehydration [see Warnings and Precautions (5.3)]<BR>                     <BR>                     Persistent or recurrent coughing, wheezing, dyspnea, or new onset facial swelling [see Warnings and Precautions (5.4), and Adverse Reactions (6.1)]<BR>                     <BR>                     Pregnancy or nursing [see Use in Specific Populations (8.1, 8.3)]<BR>                     <BR>                  <BR>                  Advise patients of the need for:<BR>                  <BR>                     Periodic monitoring of electrolytes [see Warnings and Precautions (5.5)]<BR>                     <BR>                     Limitation of sun exposure (use sunscreen, wear hats) while receiving Vectibix and for 2 months after the last dose of Vectibix therapy [see Warnings and Precautions (5.6)]<BR>                     <BR>                     Adequate contraception in both males and females while receiving Vectibix and for 6 months after the last dose of Vectibix therapy [see Use in Specific Populations (8.1, 8.3)]<BR>                     <BR>                  <BR>               <BR>               <BR>               <BR>                  <BR>                     <BR>                     <BR>                     <BR>                     <BR>                        [Amgen logo]<BR>                        Vectibix® (panitumumab)<BR>Manufactured by:<BR>Amgen Inc.<BR>One Amgen Center Drive<BR>Thousand Oaks, CA 91320-1799 USA<BR>                        Patent:  http://pat.amgen.com/vectibix/<BR>                        <BR>                        © 2006-2013 Amgen Inc. All rights reserved.<BR>1xxxxxx - v16<BR>PMV 16<BR>                     <BR>                     <BR>                  <BR>               <BR>            <BR>         </P></DIV></HTML>